Digital Prehabilitation for Patients Undergoing Major Elective Surgery

NCT06137781 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2025-12-17

Study results available
· View outcomes & findings →

Summary

Prehabilitation describes the process of improving someone's functional capacity before major surgery. Prehabilitation commonly focuses on exercise training, as fitness level is a predictor of surgical outcomes - the fitter you are before surgery, the lower the risk of complications after surgery. Typically, exercise training is done at the hospital, but research shows that patients would prefer to do prehabilitation exercises in their home.

The goal of this study is to test the feasibility of an online prehabilitation programme made by PreActiv, which can be accessed at home via a website by patients who are awaiting major surgery. PreActiv's prehabilitation programme is six weeks long, and involves three 35-minute exercise sessions per week, with each session including a warm-up, cardio exercises, muscle strengthening exercises, and breathing exercises. Information from this pilot study on the number of exercise sessions attended (adherence) and the number of patients who complete the study (retention) will be used to decide whether we should progress to a larger study that assesses the effectiveness of PreActiv's prehabilitation.

Conditions

  • Surgery

Interventions

BEHAVIORAL

Six weeks of digital prehabilitation

All participants will be allocated to receive six weeks of digital prehabilitation via PreActiv's website, plus usual care.

Sponsors & Collaborators

  • University of Bath

    collaborator OTHER
  • PreActiv

    collaborator UNKNOWN
  • Royal United Hospitals Bath NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Alec Snow, MBChB · Royal United Hospitals Bath NHS Foundation Trust

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-19
Primary Completion
2024-09-17
Completion
2024-09-17

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06137781 on ClinicalTrials.gov